Skip to main content
. 2013 Jan 24;8(1):e53190. doi: 10.1371/journal.pone.0053190

Figure 3. Growth inhibition of Jurkat cells transfected with FLT3 expression constructs (FLT3-ITD, FLT3-wt, and empty vector) and treated with Sorafenib, PKC412, TKI258 and AraC.

Figure 3

IC50 was determined by WST-1 assay with different concentrations.